Mark Sheptoff Financial Planning’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2021
         Q4  | – | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | $6K | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | $8K | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | $9K | Hold | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $12K | Buy | 
         | 
    |||||
| 
        
          
      
        2020
         Q3  | $5K | Hold | 
         | 
    |||||
| 
        
          
      
        2020
         Q2  | $7K | Hold | 
         | 
    |||||
| 
        
          
      
        2020
         Q1  | $4K | Sell | 
         | 
    |||||
| 
        
          
      
        2019
         Q4  | $14K | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q3  | $10K | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q2  | $9K | Hold | 
         | 
    |||||
| 
        
          
      
        2019
         Q1  | $9K | Buy | 
         | 
    |||||
| 
        
          
      
        2018
         Q4  | $6K | Sell | 
         | 
    |||||
| 
        
          
      
        2018
         Q3  | $41K | Hold | 
         | 
    |||||
| 
        
          
      
        2018
         Q2  | $57K | Hold | 
         | 
    |||||
| 
        
          
      
        2018
         Q1  | $49K | Buy | 
         | 
    |||||
| 
        
          
      
        2017
         Q4  | $33K | Buy | 
         | 
    |||||
| 
        
          
      
        2017
         Q3  | $27K | Hold | 
         | 
    |||||
| 
        
          
      
        2017
         Q2  | $22K | Buy | 
         |